Advanced Search

Study Preview



Study Title and Description

Physiological and bifidogenic effects of prebiotic supplements in infant formulae.



Key Questions Addressed
1 Is this an intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Physiological and bifidogenic effects of prebiotic supplements in infant formulae.
Author Veereman-Wauters G., Staelens S., Van de Broek H., Plaskie K., Wesling F., Roger LC., McCartney AL., Assam P.
Country Department of Pediatric Gastroenterology and Nutrition, UZ Brussels, Brussels, Belgium. gveereman@gmail.com
Year 2011
Numbers Pubmed ID: 21593649

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber 4.1
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
pubyear 2011
  • Comments Comments (
    0
    ) |
country Belgium
  • Comments Comments (
    0
    ) |
design Randomized Controlled Trial (parallel)
  • Comments Comments (
    0
    ) |
blindness Double blind
  • Comments Comments (
    0
    ) |
diet Isocaloric/Maintenance
  • Comments Comments (
    0
    ) |
feedcontrol All food provided (metabolic study)
  • Comments Comments (
    0
    ) |
sampsize 81
  • Comments Comments (
    0
    ) |
runin No
  • Comments Comments (
    0
    ) |
washout Not applicable
  • Comments Comments (
    0
    ) |
dosechange No
  • Comments Comments (
    0
    ) |
age_adult
  • Comments Comments (
    0
    ) |
age_adol
  • Comments Comments (
    0
    ) |
age_child
  • Comments Comments (
    0
    ) |
age_baby
  • Comments Comments (
    0
    ) |
age_infant 1
  • Comments Comments (
    0
    ) |
age_oth
  • Comments Comments (
    0
    ) |
age_mean NR
  • Comments Comments (
    0
    ) |
age_range 1-33 days
  • Comments Comments (
    0
    ) |
bmi_mean NR
  • Comments Comments (
    0
    ) |
bmi_range
  • Comments Comments (
    0
    ) |
blhealth_healthy 1
  • Comments Comments (
    0
    ) |
blhealth_hyperlip
  • Comments Comments (
    0
    ) |
blhealth_diab
  • Comments Comments (
    0
    ) |
blhealth_hyperten
  • Comments Comments (
    0
    ) |
blhealth_digest
  • Comments Comments (
    0
    ) |
blhealth_met
  • Comments Comments (
    0
    ) |
blhealth_oth
  • Comments Comments (
    0
    ) |
blhealth_othspec
  • Comments Comments (
    0
    ) |
gender ~59
  • Comments Comments (
    0
    ) |
ftype1 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip1_1 oligofructose
  • Comments Comments (
    0
    ) |
descrip1_2 long-chain inulin
  • Comments Comments (
    0
    ) |
dose1_1 0.2 g/dL
  • Comments Comments (
    0
    ) |
dose1_2 0.2 g/dL
  • Comments Comments (
    0
    ) |
duration1 28 days
  • Comments Comments (
    0
    ) |
admin1 Powder
  • Comments Comments (
    0
    ) |
ftype2 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip2_1 oligofructose
  • Comments Comments (
    0
    ) |
descrip2_2 long-chain inulin
  • Comments Comments (
    0
    ) |
dose2_1 0.4 g/dL
  • Comments Comments (
    0
    ) |
dose2_2 0.4 g/dL
  • Comments Comments (
    0
    ) |
duration2 28 days
  • Comments Comments (
    0
    ) |
admin2 Powder
  • Comments Comments (
    0
    ) |
ftype3 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip3_1 galacto-oligosaccharides
  • Comments Comments (
    0
    ) |
descrip3_2 long-chain inulin
  • Comments Comments (
    0
    ) |
dose3_1 0.72 g/dL
  • Comments Comments (
    0
    ) |
dose3_2 0.08 g/dL
  • Comments Comments (
    0
    ) |
duration3 28 days
  • Comments Comments (
    0
    ) |
admin3 Powder
  • Comments Comments (
    0
    ) |
ftype4
  • Comments Comments (
    0
    ) |
descrip4_1
  • Comments Comments (
    0
    ) |
descrip4_2
  • Comments Comments (
    0
    ) |
dose4_1
  • Comments Comments (
    0
    ) |
dose4_2
  • Comments Comments (
    0
    ) |
duration4
  • Comments Comments (
    0
    ) |
admin4
  • Comments Comments (
    0
    ) |
comparator1 control
  • Comments Comments (
    0
    ) |
cdose1 0
  • Comments Comments (
    0
    ) |
cduration1 28 days
  • Comments Comments (
    0
    ) |
cadmin1 Powder
  • Comments Comments (
    0
    ) |
comparator2 breast-fed control
  • Comments Comments (
    0
    ) |
cdose2
  • Comments Comments (
    0
    ) |
cduration2 28 days
  • Comments Comments (
    0
    ) |
cadmin2 Diet
  • Comments Comments (
    0
    ) |
comparator3
  • Comments Comments (
    0
    ) |
cdose3
  • Comments Comments (
    0
    ) |
cduration3
  • Comments Comments (
    0
    ) |
cadmin3
  • Comments Comments (
    0
    ) |
comparator4
  • Comments Comments (
    0
    ) |
cdose4
  • Comments Comments (
    0
    ) |
cduration4
  • Comments Comments (
    0
    ) |
cadmin4
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.